Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP614364.RAyQu4xJqQGd15M5i7UAdIV1WCq61b-bNbXBWWRxh-nMY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP614364.RAyQu4xJqQGd15M5i7UAdIV1WCq61b-bNbXBWWRxh-nMY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP614364.RAyQu4xJqQGd15M5i7UAdIV1WCq61b-bNbXBWWRxh-nMY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP614364.RAyQu4xJqQGd15M5i7UAdIV1WCq61b-bNbXBWWRxh-nMY130_provenance.
- NP614364.RAyQu4xJqQGd15M5i7UAdIV1WCq61b-bNbXBWWRxh-nMY130_assertion wasGeneratedBy ECO_0000203 NP614364.RAyQu4xJqQGd15M5i7UAdIV1WCq61b-bNbXBWWRxh-nMY130_provenance.
- NP614364.RAyQu4xJqQGd15M5i7UAdIV1WCq61b-bNbXBWWRxh-nMY130_assertion wasDerivedFrom befree-20140225 NP614364.RAyQu4xJqQGd15M5i7UAdIV1WCq61b-bNbXBWWRxh-nMY130_provenance.
- NP614364.RAyQu4xJqQGd15M5i7UAdIV1WCq61b-bNbXBWWRxh-nMY130_assertion SIO_000772 19864236 NP614364.RAyQu4xJqQGd15M5i7UAdIV1WCq61b-bNbXBWWRxh-nMY130_provenance.
- NP614364.RAyQu4xJqQGd15M5i7UAdIV1WCq61b-bNbXBWWRxh-nMY130_assertion evidence source_evidence_literature NP614364.RAyQu4xJqQGd15M5i7UAdIV1WCq61b-bNbXBWWRxh-nMY130_provenance.
- NP614364.RAyQu4xJqQGd15M5i7UAdIV1WCq61b-bNbXBWWRxh-nMY130_assertion description "[We compared the American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) immunohistochemical scoring criterion (30%) for determining HER2 status and the Food and Drug Administration criterion (10%) with fluorescence in situ hybridization (FISH), the HER2 gene amplification method in 328 cases of breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614364.RAyQu4xJqQGd15M5i7UAdIV1WCq61b-bNbXBWWRxh-nMY130_provenance.
- befree-20140225 importedOn "2014-02-25" NP614364.RAyQu4xJqQGd15M5i7UAdIV1WCq61b-bNbXBWWRxh-nMY130_provenance.